|
Real-time Estimate
Cboe BZX
15:29:41 2026-10-30 EDT
|
5-day change | 1st Jan Change | ||
| 601.14 USD | +1.28% |
|
+2.47% | +23.55% |
| 10-28 | United Therapeutics Insider Sold Shares Worth $5,583,418, According to a Recent SEC Filing | MT |
| 10-28 | United Therapeutics Wins FDA Clearance for Treprostinil-Iloprost Phase 1 Trial | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 25.46B | |||||
| 1,224B | |||||
| 662B | |||||
| 514B | |||||
| 388B | |||||
| 361B |
Select your edition
All financial news and data tailored to specific country editions
